Bharat Parenterals Limited (BPLPHARMA.BO)
INR 1640.0
(0.33%)
INR 1640.0
(0.33%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -47.05 Million | 207.74 Million | -16.33 Million | 306.13 Million | 145.7 Million | 199.23 Million |
| Net Income | 145.17 Million | 164.4 Million | 210.52 Million | 203.89 Million | 241.43 Million | 212.47 Million |
| Depreciation & Amortization | 90.2 Million | 57.83 Million | 65.51 Million | 59.08 Million | 58.82 Million | 60.69 Million |
| Deferred income taxes | - | -338.2 Million | -191.8 Million | -110.2 Million | - | - |
| Stock-based compensation | 1.39 Million | 5.3 Million | 6.92 Million | 4.3 Million | - | - |
| Change in working capital | -379.21 Million | -18.96 Million | -281.25 Million | 1.26 Million | -145.29 Million | -103.51 Million |
| Other non-cash items | 95.38 Million | 335.5 Million | 173.76 Million | 147.78 Million | 221.67 Million | 242.48 Million |
| Investing Cash Flow | -1.04 Billion | -483.31 Million | -25.95 Million | -481.09 Million | -135.81 Million | -97.16 Million |
| Investments in PPE | -1.04 Billion | -916 Million | -389.52 Million | -58.61 Million | -150.07 Million | -88.76 Million |
| Acquisitions | 65.05 Million | 322.93 Million | 44.44 Million | 138 Thousand | 1.68 Million | 700 Thousand |
| Investment purchases | -12.54 Million | -8.48 Million | -5.26 Million | -422.73 Million | - | -9.77 Million |
| Sales/Maturities of investments | - | 118.24 Million | 324.37 Million | - | 11.85 Million | - |
| Other Investing Activities | -4.81 Million | 137.81 Million | 1000.00 | 120 Thousand | 719 Thousand | 674 Thousand |
| Financing Cash Flow | 1.1 Billion | 319.98 Million | 59.51 Million | 90.7 Million | -19.52 Million | -30.24 Million |
| Debt repayment | -622.42 Million | -319.98 Million | -55.05 Million | -90.7 Million | -19.52 Million | -30.24 Million |
| Dividends payments | -4.33 Million | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 4.45 Million | - | 4.45 Million | - | - | - |
| Other Financing Activities | 486.18 Million | 618.41 Million | 10.64 Million | 7.51 Million | -8.64 Million | -1000.00 |
| Accounts receivables | -279.93 Million | -390.92 Million | -46.61 Million | 112.85 Million | -157.33 Million | -64.12 Million |
| Accounts payables | 86.28 Million | 346.38 Million | -23.96 Million | -164.41 Million | 106.97 Million | 53.55 Million |
| Inventory | -236.25 Million | -170.81 Million | 16.72 Million | 63.83 Million | -62.92 Million | -80.94 Million |
| Other working capital | 136.97 Million | 196.39 Million | -227.4 Million | -11.01 Million | -32 Million | -11.99 Million |
| Cash at beginning of period | 78.41 Million | 46.63 Million | 24.15 Million | 103.86 Million | 121.17 Million | 41.12 Million |
| Cash at end of period | 87.79 Million | 89.1 Million | 46.63 Million | 24.15 Million | 103.86 Million | 121.17 Million |
| Capital Expenditure | -1.04 Billion | -916 Million | -389.52 Million | -58.61 Million | -150.07 Million | -88.76 Million |
| Effect of forex changes on cash | - | -14.25 Million | -700 Thousand | - | - | -1000.00 |
| Net cash flow / Change in cash | 9.38 Million | 42.47 Million | 22.47 Million | -79.7 Million | -17.31 Million | 80.05 Million |
| Free Cash Flow | -1.09 Billion | -708.26 Million | -405.85 Million | 247.51 Million | -4.36 Million | 110.46 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 12.8 Million | -3.02 Million | 145.17 Million | 37.8 Million | 35.2 Million | 75.2 Million |
| Depreciation & Amortization | - | - | 89.29 Million | 18.2 Million | - | 15.8 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | 1.39 Million | 1.39 Million | - | - | - |
| Change in working capital | - | - | -292.93 Million | - | - | - |
| Other non-cash items | -12.8 Million | 1.63 Million | 588.81 Million | -37.8 Million | -35.2 Million | -75.2 Million |
| Investing Cash Flow | - | - | -990.51 Million | - | - | - |
| Investments in PPE | - | - | -1.04 Billion | - | - | - |
| Acquisitions | - | - | 65.05 Million | - | - | - |
| Investment purchases | - | - | -12.54 Million | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -4.81 Million | - | - | - |
| Financing Cash Flow | - | - | 1.07 Billion | - | - | - |
| Debt repayment | - | - | -1.07 Billion | - | - | - |
| Dividends payments | - | - | -4.33 Million | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 4.45 Million | - | - | - |
| Other Financing Activities | - | - | 486.18 Million | - | - | - |
| Accounts receivables | - | - | -280.35 Million | - | - | - |
| Accounts payables | - | - | 86.28 Million | - | - | - |
| Inventory | - | - | -236.25 Million | - | - | - |
| Other working capital | - | - | 137.38 Million | - | - | - |
| Cash at beginning of period | - | - | 89.1 Million | - | - | 99.8 Million |
| Cash at end of period | - | - | 99.26 Million | 36.4 Million | - | 75.2 Million |
| Capital Expenditure | - | - | -1.04 Billion | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | 10.16 Million | 36.4 Million | - | -24.6 Million |
| Free Cash Flow | - | - | -1.12 Billion | 36.4 Million | - | 75.2 Million |
3091
0LIU
002713
8967
002396
LRKKF